Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. (2014)
Attributed to:
MRC Centre for Transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1400419111
PubMed Identifier: 24492375
Publication URI: http://europepmc.org/abstract/MED/24492375
Type: Journal Article/Review
Volume: 111
Parent Publication: Proceedings of the National Academy of Sciences of the United States of America
Issue: 7
ISSN: 0027-8424